ABVC Biopharma Inc. Issues Correction on Accounting Firm Engagement Status
I'm PortAI, I can summarize articles.
ABVC Biopharma Inc. has corrected its Current Report on Form 8-K/A regarding the non-renewal of engagement by WWC, P.C., its independent accounting firm, effective October 10, 2024. WWC has not provided a letter confirming agreement with the original report's statements. The update was signed by CEO Uttam Patil on September 12, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments